Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 98

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 98
---

the attention of management and cause NewGenIvf to incur various expenses in identifying, investigating and pursuing suitable opportunities,
whether or not the transactions are completed, and may result in unforeseen operating difficulties and expenditures. In particular, NewGenIvf
may encounter difficulties assimilating or integrating the businesses, technologies, products and services, personnel or operations of
the acquired companies, particularly if the key personnel of the acquired company choose not to work for it, they are operationally difficult
to integrate, or NewGenIvf has difficulty retaining the clients of any acquired business due to changes in ownership, management or otherwise.
These transactions may also disrupt its business, divert its resources, and require significant management attention that would otherwise
be available for development of its existing business and may not benefit NewGenIvf’s business strategy, may not generate sufficient
revenues to offset the associated acquisition costs or may not otherwise result in the intended benefits. Any such transactions that NewGenIvf
is able to complete may not result in any synergies or other benefits it had expected to achieve, which could result in impairment charges
that could be substantial. In addition, NewGenIvf may not be able to find and identify desirable acquisition targets or business opportunities
or be successful in entering into an agreement with any particular strategic partner. These transactions could also result in dilutive
issuances of equity securities or the incurrence of debt, which could adversely affect its results of operations. In addition, if the
resulting business from such a transaction fails to meet NewGenIvf’s expectations, or it fails to successfully integrate such businesses
into its own, its business, financial condition and results of operations may be adversely affected or it may be exposed to unknown risks
or liabilities. Even when NewGenIvf identifies an appropriate acquisition or investment target, it may not be able to negotiate the terms
of the acquisition or investment successfully, obtain financing for the proposed transaction, or integrate the relevant businesses into
its existing business and operations. Strategic investments or acquisitions will involve risks commonly encountered in business relationships,
including:

| ● | difficulties in assimilating and integrating the operations, personnel, systems, data, technologies, products and services of the acquired business; |

| ● | inability of the acquired technologies, products or businesses to achieve expected levels of revenue, profitability, productivity or other benefits; |

| ● | difficulties in retaining, training, motivating and integrating key personnel; |

| ● | diversion of management’s time and resources from NewGenI